AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27435610 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (transcutaneous electrical stimulation) in mild-to-moderate OSA subgroup
Number of subjects: 36
Study 25258014 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (20% kcal)
Number of subjects: 48835
Study 22250210 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation of the common peroneal nerve to generate an afferent volley timed to arrive during specific phases of the cortical potential during motor imagination (50 repetitions).
Number of subjects: 0
Study 22250210 — intervention group
Group type: EXPERIMENTAL
Intervention: Afferent volley arriving during the peak negative deflection of the cortical potential.
Number of subjects: 0
Study 22250210 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificially generated signal (peripheral afferent volley) interacting with physiologically generated signal during imagined movement.
Number of subjects: 0
Study 20722556 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 32
Study 20722556 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 32
Study 17853277 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine 300 mg/day
Number of subjects: 351
Study 17853277 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine 600 mg/day
Number of subjects: 351
Study 17853277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study 17853277 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine 300 mg/day and 600 mg/day
Number of subjects: 351
Study 16027809 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (Zocor)
Number of subjects: 0
Study 16027809 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation of polyunsaturated phospholipids (lipostabil forte)
Number of subjects: 0
Study 12823127 — intervention group
Group type: EXPERIMENTAL
Intervention: Active SLIT
Number of subjects: 24
Study 12823127 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 14971863 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine (450 mg/day)
Number of subjects: 13
Study 14971863 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine (50 mg/day)
Number of subjects: 13
Study 10466877 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg daily for 10 days)
Number of subjects: 10
Study 10466877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8682927 — intervention group
Group type: EXPERIMENTAL
Intervention: PerioGard test kit
Number of subjects: 106
Study 8682927 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (healthy sites)
Number of subjects: 106
Study 2193420 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft ski boots
Number of subjects: 33
Study 2193420 — intervention group
Group type: COMPARATOR
Intervention: Stiff ski boots
Number of subjects: 33
Study 442014 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐ASA (Dipyridamole 30 mg and ASA 300 mg administered intravenously two hours before surgery, then orally three times a day in tablets containing dipyridamole 50 mg and ASA 330 mg)
Number of subjects: 146
Study 442014 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of Heparin (5000 IU subcutaneously twice a day starting two hours pre-operatively)
Number of subjects: 146
Study 442014 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 146
Study 28665937 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 100,000 UI/week for 3 months
Number of subjects: 32
Study 28665937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 26116485 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoscopic lung volume reduction (endobronchial valves)
Number of subjects: 50
Study 26116485 — intervention group
Group type: COMPARATOR
Intervention: Sham valve placement (control)
Number of subjects: 50
Study 23277262 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 149
Study 23277262 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 149
Study 23277262 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 149
Study 23277262 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine
Number of subjects: 149
Study 20932709 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted, patient-specific navigational templates for hip resurfacing arthroplasty
Number of subjects: 0
Study 19465372 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy interventions
Number of subjects: 0
Study 19465372 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality randomized controlled trials
Number of subjects: 0
Study 19465372 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical interactions analysis
Number of subjects: 0
Study 19465372 — intervention group
Group type: EXPERIMENTAL
Intervention: External validation
Number of subjects: 0
Study 17318449 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention (details not specified)
Number of subjects: 268
Study 15616408 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 0
Study 15616408 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonconventional forms of physical exercise (including yoga)
Number of subjects: 0
Study 11710409 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate (0.5 g x kg(-1) body mass)
Number of subjects: 9
Study 11710409 — intervention group
Group type: COMPARATOR
Intervention: NaCl (0.1 g x kg(-1) body mass)
Number of subjects: 9
Study 9205017 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg, titrated to 20 mg if needed
Number of subjects: 177
Study 9205017 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 10 mg, titrated to 20 mg if needed
Number of subjects: 177
Study 9205017 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 177
Study 9205017 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 177
Study 7963867 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 315
Study 7963867 — intervention group
Group type: COMPARATOR
Intervention: Non-operated group
Number of subjects: 315
Study 3655863 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Magnetic Resonance Imaging (MRI)
Number of subjects: 31
Study 3655863 — intervention group
Group type: COMPARATOR
Intervention: Conventional Myelography
Number of subjects: 31
Study 30334639 — intervention group
Group type: EXPERIMENTAL
Intervention: Verinurad 5 mg
Number of subjects: 375
Study 30334639 — intervention group
Group type: EXPERIMENTAL
Intervention: Verinurad 10 mg
Number of subjects: 375
Study 30334639 — intervention group
Group type: EXPERIMENTAL
Intervention: Verinurad 12.5 mg
Number of subjects: 375
Study 30334639 — intervention group
Group type: EXPERIMENTAL
Intervention: Verinurad 2.5 mg
Number of subjects: 375
Study 30334639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study 28679683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) at 10°C
Number of subjects: 19
Study 28679683 — intervention group
Group type: COMPARATOR
Intervention: Passive room temperature control at 23°C
Number of subjects: 19
Study 28679683 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular postexercise CWI
Number of subjects: 19
Study 28679683 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (6 weeks)
Number of subjects: 19
Study 28679683 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular CWI after 6 weeks of SIT
Number of subjects: 19
Study 26125101 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic methotrexate (MTX)
Number of subjects: 64
Study 26125101 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 64
Study 23505198 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese individuals classified by BMI (≥ 30 kg/m(2)) and BF% (≥ 25% for men and ≥ 35% for women) (OO)
Number of subjects: 486
Study 23505198 — intervention group
Group type: COMPARATOR
Intervention: Nonobese individuals classified by BMI but obese by BF% (NOO)
Number of subjects: 486
Study 21831359 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER Medium (3 mg)
Number of subjects: 201
Study 21831359 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER Low (1.5 mg)
Number of subjects: 201
Study 21831359 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER High (6 mg)
Number of subjects: 201
Study 21831359 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER (3 mg)
Number of subjects: 201
Study 21831359 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER (6 mg)
Number of subjects: 201
Study 21831359 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER (12 mg)
Number of subjects: 201
Study 21831359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 19594486 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib or Diclofenac with reminders and free PPI
Number of subjects: 10026
Study 17676687 — intervention group
Group type: EXPERIMENTAL
Intervention: CD-ROM-delivered CBT
Number of subjects: 0
Study 17676687 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 weekly group CBT sessions
Number of subjects: 0
Study 17676687 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (WL)
Number of subjects: 0
Study 14987325 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy
Number of subjects: 42
Study 14987325 — intervention group
Group type: COMPARATOR
Intervention: Calcium and vitamin D alone
Number of subjects: 42
Study 11588633 — intervention group
Group type: EXPERIMENTAL
Intervention: GON infiltration with bupivacaina 0.5% (BP)
Number of subjects: 37
Study 11588633 — intervention group
Group type: COMPARATOR
Intervention: Physiological serum 0.9% (PS)
Number of subjects: 37
Study 9674375 — intervention group
Group type: COMPARATOR
Intervention: Running on surfaced footpath
Number of subjects: 9
Study 9674375 — intervention group
Group type: EXPERIMENTAL
Intervention: Running on short grass
Number of subjects: 9
Study 9674375 — intervention group
Group type: EXPERIMENTAL
Intervention: Running on long grass
Number of subjects: 9
Study 8078162 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized developmental care by trained nurses
Number of subjects: 38
Study 8078162 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 38
Study 2491940 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 42
Study 2491940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 55838 — intervention group
Group type: EXPERIMENTAL
Intervention: high-titre HbsAb gamma-globulin
Number of subjects: 279
Study 55838 — intervention group
Group type: EXPERIMENTAL
Intervention: normal gamma-globulin
Number of subjects: 279
Study 55838 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 279
Study 31944363 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy weight control behaviors (purging and nonpurging)
Number of subjects: 690
Study 31944363 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of being overweight
Number of subjects: 690
Study 31944363 — intervention group
Group type: EXPERIMENTAL
Intervention: Being overweight
Number of subjects: 690
Study 31944363 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe depression
Number of subjects: 690
Study 31944363 — intervention group
Group type: EXPERIMENTAL
Intervention: High socio-economic status
Number of subjects: 690
Study 30293664 — intervention group
Group type: EXPERIMENTAL
Intervention: ranolazine
Number of subjects: 81
Study 30293664 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 81
Study 28991664 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA treatment
Number of subjects: 0
Study 28991664 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation treatment (control group)
Number of subjects: 0
Study 28991664 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 26659934 — intervention group
Group type: EXPERIMENTAL
Intervention: Botanical anti-inflammatory acne regimen
Number of subjects: 80
Study 26659934 — intervention group
Group type: COMPARATOR
Intervention: Traditional benzoyl peroxide comparator
Number of subjects: 80
Study 24003870 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive gestational weight gain based on the IOM recommendations
Number of subjects: 298
Study 24003870 — intervention group
Group type: COMPARATOR
Intervention: Appropriate gestational weight gain based on the IOM recommendations
Number of subjects: 298
Study 24003870 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepregnancy BMI
Number of subjects: 298
Study 24003870 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 298
Study 21869712 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone hexacetonide (TAH) 20 mg
Number of subjects: 30
Study 21869712 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TA) 40 mg
Number of subjects: 30
Study 21869712 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) injection
Number of subjects: 30
Study 18543492 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Yangyin Jiedu Decoction (YYJD)
Number of subjects: 60
Study 18543492 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (NP or GP protocol)
Number of subjects: 60
Study 18543492 — intervention group
Group type: EXPERIMENTAL
Intervention: YYJD and chemotherapy in combination
Number of subjects: 60
Study 18543492 — intervention group
Group type: EXPERIMENTAL
Intervention: YYJD
Number of subjects: 60
Study 16865869 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 43
Study 16865869 — intervention group
Group type: EXPERIMENTAL
Intervention: MAL-PDT
Number of subjects: 43
Study 14692211 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Total Advanced Fresh toothpaste (0.30% triclosan, 2% PVM/MA copolymer, 0.243% sodium fluoride)
Number of subjects: 81
Study 14692211 — intervention group
Group type: COMPARATOR
Intervention: Colgate Cavity Protection Winterfresh Gel (0.243% sodium fluoride)
Number of subjects: 81
Study 10853878 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg orally once a day for 4 days
Number of subjects: 10
Study 10853878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9115000 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms EE2 + 75 micrograms GSD
Number of subjects: 0
Study 9115000 — intervention group
Group type: COMPARATOR
Intervention: 30 micrograms EE2 + 75 micrograms GSD
Number of subjects: 0
Study 9115000 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 8465010 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐ or postoperative megavoltage radiation therapy (45 Gy/5 weeks)
Number of subjects: 960
Study 8465010 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 960
Study 8465010 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐ or postoperative megavoltage radiation therapy
Number of subjects: 960
Study 3022694 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam
Number of subjects: 52
Study 3022694 — intervention group
Group type: COMPARATOR
Intervention: Corticotropin
Number of subjects: 52
Study 30339635 — intervention group
Group type: EXPERIMENTAL
Intervention: Low plasma gelsolin levels (below the 25th percentile) in medical patients
Number of subjects: 746
Study 30339635 — intervention group
Group type: EXPERIMENTAL
Intervention: Low plasma gelsolin levels (below the 25th percentile) in both medical and surgical patients
Number of subjects: 746
Study 30339635 — intervention group
Group type: EXPERIMENTAL
Intervention: Low plasma gelsolin levels
Number of subjects: 746
Study 29563027 — intervention group
Group type: EXPERIMENTAL
Intervention: PARO robotic seal (15-min sessions three afternoons per week for 10 weeks)
Number of subjects: 28
Study 29563027 — intervention group
Group type: COMPARATOR
Intervention: Plush toy (PARO with robotic features disabled)
Number of subjects: 28
Study 29563027 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study 26981628 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Short-Message-Service-Based Disease Outbreak Alert System
Number of subjects: 0
Study 26981628 — intervention group
Group type: COMPARATOR
Intervention: Control group (no text-messaging system)
Number of subjects: 0
Study 25227114 — intervention group
Group type: EXPERIMENTAL
Intervention: Early goal-directed therapy using arterial waveform analysis
Number of subjects: 542
Study 25227114 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 542
Study 22662775 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 insufflation during ileo-colonoscopy (132 patients)
Number of subjects: 309
Study 22662775 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 insufflation during ileo-colonoscopy plus gastroscopy (53 patients)
Number of subjects: 309
Study 22662775 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation during ileo-colonoscopy (82 patients)
Number of subjects: 309
Study 22662775 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation during ileo-colonoscopy plus gastroscopy (42 patients)
Number of subjects: 309
Study 20144066 — intervention group
Group type: EXPERIMENTAL
Intervention: Benidipine (4-8 mg/day) combined with olmesartan (10 mg/day)
Number of subjects: 17
Study 20144066 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (5-10 mg/day) combined with olmesartan (10 mg/day)
Number of subjects: 17
Study 20144066 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens (benidipine and amlodipine)
Number of subjects: 17
Study 18042477 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 650
Study 18042477 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 650
Study 18042477 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 650
Study 18042477 — intervention group
Group type: COMPARATOR
Intervention: TMP/SMX
Number of subjects: 650
Study 18042477 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall fluoroquinolone susceptibility
Number of subjects: 650
Study 15523335 — intervention group
Group type: EXPERIMENTAL
Intervention: Channel length of 9.0 mm
Number of subjects: 240
Study 15523335 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance of 4.0 mm
Number of subjects: 240
Study 15523335 — intervention group
Group type: EXPERIMENTAL
Intervention: Varying diameters, lengths, and distances
Number of subjects: 240
Study 11213073 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/day sirolimus
Number of subjects: 576
Study 11213073 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day sirolimus
Number of subjects: 576
Study 11213073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study 9627862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (800 mg 3 times a day for 1 week, 800 mg twice a day for 1 week, and 800 mg as needed to a maximum daily dose of 2400 mg for 7 weeks) and nocturnal wrist supports
Number of subjects: 91
Study 9627862 — intervention group
Group type: COMPARATOR
Intervention: Chiropractic treatment (manipulation of soft tissues and bony joints of the upper extremities and spine, ultrasound over the carpal tunnel, and nocturnal wrist supports)
Number of subjects: 91
Study 7877194 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (37.5-75 mg/d)
Number of subjects: 60
Study 7877194 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (40-80 mg/d)
Number of subjects: 60
Study 3048092 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime (400 mg once daily)
Number of subjects: 560
Study 3048092 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (250 or 500 mg three times daily)
Number of subjects: 560
Study 30041105 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized church reports including church capacity scores and recommendations for health promotion programming.
Number of subjects: 14
Study 30041105 — intervention group
Group type: EXPERIMENTAL
Intervention: Meetings with church leaders to review reports.
Number of subjects: 14
Study 28080323 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of ATP as disodium salt
Number of subjects: 42
Study 28080323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 25824543 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 0
Study 24135085 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes prevention program (DPP) consisting of an individual session followed by five group sessions at two-week intervals and two follow-up telephone calls.
Number of subjects: 574
Study 24135085 — intervention group
Group type: COMPARATOR
Intervention: Usual care from general practitioners.
Number of subjects: 574
Study 21145923 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 second condition with unpleasant foregrounds
Number of subjects: 36
Study 21145923 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 second condition with pleasant foregrounds
Number of subjects: 36
Study 21145923 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 second condition for heart rate (HR)
Number of subjects: 36
Study 21145923 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 millisecond condition with pleasant foregrounds
Number of subjects: 36
Study 21145923 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 millisecond condition with unpleasant foregrounds
Number of subjects: 36
Study 21145923 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 millisecond condition for heart rate (HR)
Number of subjects: 36
Study 18327678 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 100
Study 18327678 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 17163255 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 1g plus ciprofloxacin 500mg
Number of subjects: 10
Study 17163255 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 1g
Number of subjects: 10
Study 14586376 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovum donor in vitro fertilization
Number of subjects: 64